{"transactions":[{"id":893796,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":65690,"kind":"person","name":"Fortney Kristen","position":1,"cik":"0002032751","reported_name":"Fortney Kristen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-19T16:36:41.000Z","date":"2026-02-17","kind":"grant","planned":false,"acquired":true,"shares":330000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vested or vests as to 1/48th of the total award monthly, with the first tranche vested on February 1, 2026, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date."}],"balance_after":330000,"derivative":{"exercise_price":19.63,"expiration_date":"2036-02-16","underlying":"Common Stock","underlying_shares":330000},"source":{"system":"sec-edgar","filing":"0002032751-26-000010","document":"form4-02192026_090238.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2032751/000203275126000010/form4-02192026_090238.xml","form_type":"4"}},{"id":938611,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":65690,"kind":"person","name":"Fortney Kristen","position":1,"cik":"0002032751","reported_name":"Fortney Kristen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-15T16:20:14.000Z","date":"2026-01-13","kind":"sale","planned":true,"acquired":false,"shares":233107,"price":18.1163,"value":4223036.3441,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.385 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":976949,"source":{"system":"sec-edgar","filing":"0002032751-26-000003","document":"form4-01152026_090111.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2032751/000203275126000003/form4-01152026_090111.xml","form_type":"4"}},{"id":1256320,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":65690,"kind":"person","name":"Fortney Kristen","position":1,"cik":"0002032751","reported_name":"Fortney Kristen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-20T16:17:02.000Z","date":"2025-02-18","kind":"grant","planned":false,"acquired":true,"shares":530000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on February 1, 2025, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date."}],"balance_after":530000,"derivative":{"exercise_price":4.38,"expiration_date":"2035-02-17","underlying":"Common Stock","underlying_shares":530000},"source":{"system":"sec-edgar","filing":"0001415889-25-004857","document":"form4-02202025_090259.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2032751/000141588925004857/form4-02202025_090259.xml","form_type":"4"}},{"id":1398560,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":65690,"kind":"person","name":"Fortney Kristen","position":1,"cik":"0002032751","reported_name":"Fortney Kristen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-27T16:25:27.000Z","date":"2024-04-17","kind":"grant","planned":false,"acquired":true,"shares":708044,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"This option award represents an equity security previously reported on the reporting person's Form 3, which was acquired through an exempt transaction with the Issuer prior to the Issuer registering a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended. It is reported herein as a transaction pursuant to Rule 16a-2(a)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on May 17, 2024, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. Additionally, the entire award is exercisable at any time pursuant to an early exercise feature of the option award."}],"balance_after":708044,"derivative":{"exercise_price":8.39,"expiration_date":"2034-04-16","underlying":"Common Stock","underlying_shares":708044},"source":{"system":"sec-edgar","filing":"0001415889-24-024045","document":"form4-09272024_080922.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2032751/000141588924024045/form4-09272024_080922.xml","form_type":"4"}},{"id":1398559,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":65690,"kind":"person","name":"Fortney Kristen","position":1,"cik":"0002032751","reported_name":"Fortney Kristen","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-27T16:25:27.000Z","date":"2024-09-25","kind":"grant","planned":false,"acquired":true,"shares":424827,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest as to 1/48th of the total award monthly, with the first tranche vesting on October 25, 2024, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date."}],"balance_after":424827,"derivative":{"exercise_price":18,"expiration_date":"2034-09-24","underlying":"Common Stock","underlying_shares":424827},"source":{"system":"sec-edgar","filing":"0001415889-24-024045","document":"form4-09272024_080922.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2032751/000141588924024045/form4-09272024_080922.xml","form_type":"4"}}]}